ProCE Banner Activity

Q&A: Management of Eosinophilic Esophagitis: Opportunities for Pharmacists to Increase Awareness and Optimize Care

Clinical Thought

In this commentary, expert faculty provide answers to questions posed at the AMCP Annual Meeting on the pharmacist’s role in the management of eosinophilic esophagitis (EoE) and strategies to optimize transitions of care.

Released: April 12, 2023

Share

Faculty

Brian A. Hemstreet

Brian A. Hemstreet, PharmD, FCCP, BCPS

Associate Dean and Professor
Department of Clinical Pharmacy
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado

Erin Hamai Tom

Erin Hamai Tom, PharmD, APh, MBA, BCACP, CSP

Clinical Manager
Specialty Pharmacy
UC Davis Health
Sacramento, California

Provided by

Provided by ProCE, LLC

ProCE Banner

Supporters

This activity is supported by educational grants from Regeneron Pharmaceuticals, Inc., and Sanofi.

Regeneron Pharmaceuticals, Inc.

Sanofi

Faculty Disclosure

Primary Author

Brian A. Hemstreet, PharmD, FCCP, BCPS

Associate Dean and Professor
Department of Clinical Pharmacy
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado

Brian Hemstreet, PharmD, FCCP, BCPS, has no relevant financial relationships to disclose.

Erin Hamai Tom, PharmD, APh, MBA, BCACP, CSP

Clinical Manager
Specialty Pharmacy
UC Davis Health
Sacramento, California

Erin Tom, PharmD, APh, MBA, BCACP, CSP: consultant/advisor/speaker: Janssen.